Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 30651-30700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06566560
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
NARecruiting
2,500 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT06288815
Oral Fluid vs IV Fluid After Primary TKA
NARecruiting
130 participants
Started: Jan 10, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06250686
Exercise and Nutrition Intervention in Ovarian Cancer
NARecruiting
185 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2025
4 conditions7 sponsors7 locations
NCT06087341
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
PHASE1Recruiting
18 participants
Started: Jan 10, 2024 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT06162832
Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft
PHASE2Recruiting
30 participants
Started: Jan 10, 2024 · Completed: Jan 15, 2025
1 condition3 sponsors1 location
NCT06144268
Live Birth Rate After Sperm Selection Using ZyMōt Multi (850µL) Device for Intra Uterine Insemination
NARecruiting
240 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06180798
Cold Snare Endoscopic Mucosal Resection (C-EMR) Versus Hot Snare Endoscopic Mucosal Resection (H-EMR) for Large Colorectal Polyps (10-20 mm)
NARecruiting
330 participants
Started: Jan 10, 2024 · Completed: Dec 30, 2024
3 conditions1 sponsor1 location
NCT06537440
Electroacupuncture for Opioid-Induced Constipation in Cancer Patients: A Randomized Clinical Trial
NARecruiting
88 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06071299
Impact of Family-Centered Care for Intimate Partner Violence (IPV)
NARecruiting
200 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT06368076
High-intensity Interval Training in Patients With Spinal Muscular Atrophy
NARecruiting
20 participants
Started: Jan 9, 2024 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06061445
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
NARecruiting
22 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06205433
Evaluating the Impact of Training for IHSS Workers
NARecruiting
2,500 participants
Started: Jan 9, 2024 · Completed: Jun 30, 2029
1 condition4 sponsors1 location
NCT06236256
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
NARecruiting
40 participants
Started: Jan 9, 2024 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT06278454
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)
PHASE1Recruiting
58 participants
Started: Jan 9, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor6 locations
NCT05991414
The Effect of Pharmacist-Initiated Home Blood Pressure Monitoring on Blood Pressure Control in Women
NARecruiting
368 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor26 locations
NCT06409065
Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers
NARecruiting
400 participants
Started: Jan 9, 2024 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06836557
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
PHASE3Recruiting
100 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT06089707
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
PHASE3Recruiting
25 participants
Started: Jan 9, 2024 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT05397951
The Validation Study of Bioelectronics
NARecruiting
22 participants
Started: Jan 9, 2024 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT06101810
The Efficacy of Treatments to Improve Self-esteem
NARecruiting
70 participants
Started: Jan 9, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05933954
The Effects of 5G Radiation on Skin
NARecruiting
42 participants
Started: Jan 9, 2024 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05944562
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
PHASE1Recruiting
36 participants
Started: Jan 9, 2024 · Completed: Jan 31, 2030
3 conditions5 sponsors1 location
NCT06244940
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
NARecruiting
200 participants
Started: Jan 9, 2024 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06167317
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
PHASE1Recruiting
254 participants
Started: Jan 9, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor7 locations
NCT06213610
Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
PHASE1Recruiting
50 participants
Started: Jan 9, 2024 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05787197
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
N/ARecruiting
232 participants
Started: Jan 9, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor16 locations
NCT06407128
Valvular Microbiota and Valvulopathy
NARecruiting
100 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06115486
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
NARecruiting
30 participants
Started: Jan 9, 2024 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT05996822
Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant
N/ARecruiting
34 participants
Started: Jan 9, 2024 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05852158
Antibiotics for Prevention of Infection Following Orthognathic Surgery
PHASE4Recruiting
400 participants
Started: Jan 9, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05677321
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
N/ARecruiting
475 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06114628
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
PHASE2Recruiting
2,500 participants
Started: Jan 9, 2024 · Completed: Aug 11, 2027
1 condition30 sponsors11 locations
NCT06749990
Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation
N/ARecruiting
320 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT06515288
Nutrition Goes to School: a School-based Nutrition Intervention to Promote Healthy Eating Behaviour Among Adolescents
NARecruiting
1,000 participants
Started: Jan 9, 2024 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT06263660
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
PHASE2Recruiting
75 participants
Started: Jan 9, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06238232
Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism
NARecruiting
320 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2027
1 condition10 sponsors1 location
NCT05927142
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
PHASE1/PHASE2Recruiting
43 participants
Started: Jan 9, 2024 · Completed: Apr 30, 2027
1 condition3 sponsors1 location
NCT04846803
Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
NARecruiting
80 participants
Started: Jan 9, 2024 · Completed: Dec 1, 2027
1 condition1 sponsor2 locations
NCT05926492
A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma
PHASE2Recruiting
160 participants
Started: Jan 9, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06416696
Toripalimab for High-risk Locally Advanced Cervical Cancer
PHASE2Recruiting
130 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05968898
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
NARecruiting
300 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor3 locations
NCT06003283
Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
PHASE4Recruiting
134 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors7 locations
NCT06593041
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
N/ARecruiting
450 participants
Started: Jan 9, 2024 · Completed: Jan 9, 2029
6 conditions1 sponsor1 location
NCT06208280
F01 in the Treatment of Autoimmune Diseases
PHASE1Recruiting
20 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05566873
Testing Multi-Level Remote Physical Activity Interventions in a National Sample of Older Women: The WHISH EnCore Trial
NARecruiting
232 participants
Started: Jan 9, 2024 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT06429735
Precise Robotically IMplanted Brain-Computer InterfacE
NARecruiting
10 participants
Started: Jan 9, 2024 · Completed: Jan 31, 2031
6 conditions1 sponsor2 locations
NCT06394934
Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients
N/ARecruiting
4,188 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2029
4 conditions2 sponsors2 locations
NCT06420726
Resistance Exercise and Creatine in Colorectal Cancer
NARecruiting
40 participants
Started: Jan 9, 2024 · Completed: Jul 22, 2025
1 condition1 sponsor1 location
NCT06123494
SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen
PHASE3Recruiting
360 participants
Started: Jan 9, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06180824
Efficacy and Safety Between Different Dilution of Insulin
NARecruiting
74 participants
Started: Jan 9, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location